Representative Latta Proposes Bill to Ban New Abortion Drugs and Require In-Person Doctor Visits
Also known as: SAVE Moms and Babies Act of 2025
Legislative Progress
Impact Analysis
Key Points
Milestones
Related News
5 articlesNew Bill: Representative Robert E. Latta introduces H.R. 685: Support And Value Expectant Moms and Babies Act of 2025
The bill prohibits the approval of new abortion drugs by the HHS Secretary and prevents investigational use exemptions for drugs in research phases. For existing drugs, it bans pharmacy dispensing and mail-order delivery, requiring in-person administration by a certified healthcare practitioner.
Additional Licensure Pathways Bill Meets Resistance
The SAVE Moms and Babies Act of 2025 (H.R. 685), introduced by Rep. Bob Latta, would prohibit the approval of new abortion drugs and label changes to existing medications. It requires administration in an office setting and imposes strict reporting requirements on adverse effects.

Hyde-Smith Bill Targets Medication Abortions with 'SAVE Moms and Babies Act'
Senator Cindy Hyde-Smith reintroduced the SAVE Moms and Babies Act to prevent the FDA from lifting regulations on abortion medication. The bill aims to block mail-order distribution and telemedicine prescriptions, while critics argue it ignores data showing serious complications are rare.